Accordingly, aberrantly activated G9a in diseased hippocampus regulates specific pathways at the translational or post-translational (phosphorylation) level that mechanistically contribute to the major symptoms of AD, including cognition impairment, memory loss, depression, and anxiety. This evidence concerns the gene EHMT2 and depressive symptom measurement.